BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 16228080)

  • 1. Mycobacterium tuberculosis and CD4+ T-lymphopenia. A grave combination.
    Aziz S; Al-Anazi AR; Al-Hedaithy MA; Al-Shobaili HA; Al-Aska AI
    Saudi Med J; 2005 Oct; 26(10):1655-7. PubMed ID: 16228080
    [No Abstract]   [Full Text] [Related]  

  • 2. Appropriateness of extending the intensive phase of treatment based on smear results.
    Enarson DA; Jindani A; Kuaban C; Lamothe F; Louissaint M; Ottmani SE; Ramarokoto H; Ridderhof JC; Urbanczik R
    Int J Tuberc Lung Dis; 2004 Jan; 8(1):114-6. PubMed ID: 14974754
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunological studies in the treatment of tuberculosis with flureniside].
    Sibirnaia RI
    Probl Tuberk; 1997; (5):27-8. PubMed ID: 9454246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tuberculosis in patients with diabetes mellitus: present-day problems].
    Karachunskiĭ MA; Kaminskaia GO; Kossiĭ IuE; Chernykh NA
    Probl Tuberk Bolezn Legk; 2006; (10):17-9. PubMed ID: 17139826
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunological indices of patients with destructive pulmonary tuberculosis due to bovine and human Mycobacterium tuberculosis].
    Naubet'iarova AN; Syzdykova NS; Alenova AKh
    Probl Tuberk; 1987; (4):34-6. PubMed ID: 3110764
    [No Abstract]   [Full Text] [Related]  

  • 6. Alternative anti-tuberculosis regimen including ofloxacin for the treatment of patients with hepatic injury.
    Szklo A; Mello FC; Guerra RL; Dorman SE; Muzy-de-Souza GR; Conde MB
    Int J Tuberc Lung Dis; 2007 Jul; 11(7):775-80. PubMed ID: 17609053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Multidrug-resistant tuberculosis in Sweden requires increased watchfulness. A retrospective study shows low incidence--recent numbers indicate sharp increase].
    Faxén UL; Romanus V; Julander I; Petrini B; Boman G
    Lakartidningen; 2009 Jul 22-Aug 4; 106(30-31):1895-7. PubMed ID: 19739442
    [No Abstract]   [Full Text] [Related]  

  • 8. [Characteristics of infiltrative pulmonary tuberculosis located in the inferior lobe].
    Andriushina KM; Borodina NV; Savenkova DI; Oliferovskaia RP
    Klin Med (Mosk); 1985 Dec; 63(12):48-50. PubMed ID: 3937943
    [No Abstract]   [Full Text] [Related]  

  • 9. Prediction of delayed treatment response in pulmonary tuberculosis: use of time to positivity values of Bactec cultures.
    Carroll NM; Uys P; Hesseling A; Lawrence K; Pheiffer C; Salker F; Duncan K; Beyers N; van Helden PD
    Tuberculosis (Edinb); 2008 Nov; 88(6):624-30. PubMed ID: 18456556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [T-activin in the complex treatment of patients with pulmonary tuberculosis].
    Ivanova LA; Pavlova MV
    Probl Tuberk; 1986; (5):37-40. PubMed ID: 3488548
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antituberculosis antibodies in patients with tuberculosis during chemotherapy].
    Stakhanov VA; Vasil'ev NA; Levi DT; Rukhamina ML
    Probl Tuberk; 2001; (5):48-50. PubMed ID: 11588965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chemoresistance of mycobacteria in a group of patients with tuberculosis from Mureş county].
    Tarcea M; Toma F; Patraulea M; Nemeş M; Tokés C; Sabău M; Golea C
    Bacteriol Virusol Parazitol Epidemiol; 2007; 52(1-2):29-36. PubMed ID: 18441956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberculosis presenting as an endobronchial mass.
    Kreisel D; Arora N; Weisenberg SA; Saqi A; Krupnick AS; Demetriades AM; Iakovou C; Conetta R; Lee PC
    J Thorac Cardiovasc Surg; 2007 Feb; 133(2):582-4. PubMed ID: 17258612
    [No Abstract]   [Full Text] [Related]  

  • 14. Effectiveness of DOT for tuberculosis treatment outcomes: a prospective cohort study in Bangkok, Thailand.
    Okanurak K; Kitayaporn D; Wanarangsikul W; Koompong C
    Int J Tuberc Lung Dis; 2007 Jul; 11(7):762-8. PubMed ID: 17609051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4(+)CD25(+)FoxP3(+) regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease.
    Chen X; Zhou B; Li M; Deng Q; Wu X; Le X; Wu C; Larmonier N; Zhang W; Zhang H; Wang H; Katsanis E
    Clin Immunol; 2007 Apr; 123(1):50-9. PubMed ID: 17234458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are some people not safer after successful treatment of tuberculosis?
    Yew WW; Leung CC
    Am J Respir Crit Care Med; 2005 Jun; 171(12):1324-5. PubMed ID: 15941841
    [No Abstract]   [Full Text] [Related]  

  • 17. Filtrable forms of mycobacteria tuberculosis.
    Khomenko AG; Golyshevskaya VI
    Z Erkr Atmungsorgane; 1984; 162(2):147-54. PubMed ID: 6429959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with treatment success for tuberculosis patients: a single center's experience in Turkey.
    Talay F; Kumbetli S; Altin S
    Jpn J Infect Dis; 2008 Jan; 61(1):25-30. PubMed ID: 18219130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current aspects of pulmonary tuberculosis in France].
    Meyer A
    Arch Monaldi; 1972; 27(2):198-210. PubMed ID: 4633329
    [No Abstract]   [Full Text] [Related]  

  • 20. [Evaluation of care for elderly pulmonary tuberculosis patients].
    Sasaki Y; Yamagishi F; Yagi T; Hashimoto T; Bekku R; Kawasaki T; Shinozaki A
    Kekkaku; 2007 Oct; 82(10):733-9. PubMed ID: 18018597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.